A TiP-HepC Community of Practice Webinar

Although routine antenatal testing for hepatitis C is increasing, there is limited guidance when it comes to best practices regarding hepatitis C treatment for individuals diagnosed during pregnancy. As a result, very few individuals diagnosed with hepatitis C in pregnancy are successfully treated, and they remain exposed to the ongoing risks associated with chronic hepatitis C infection.

This TiP-HepC ("Treatment in Pregnancy for Hepatitis C") Community of Practice is a three-part webinar series that will focus on 1) the challenges of linkage and treatment for hepatitis C in pregnancy, 2) practical strategies and best practices to improve linkage to care and treatment, and 3) research needs to improve clinical practice and treatment coverage for pregnant persons. This webinar series will bring together clinicians, academics, researchers, advocates, professional societies, regulatory agencies and industry representatives to align on best practices to improve treatment for HCV in pregnancy. The TiP-HepC Community of Practice is intended for all stakeholders involved in the care of hepatitis C infection in pregnancy.

The first webinar on November 16th will focus on: "Challenges to HCV Linkage and Treatment in Pregnancy."

Speakers include:
Dr. Intira Jeannie Collins, Principal Research Associate, MRC Clinical Trials Unit, Institute of Clinical Trials and Methodology, University College London, UK
Dr. Saeed Hamid, Professor, Department of Medicine and Director of the Clinical Trials Unit at The Aga Khan University, Pakistan
Dr. Elizabeth E. Krans, Associate Professor of Obstetrics, Gynecology and Reproductive Medicine at the University of Pittsburgh, US

Presentations will be followed by a professional society round-table.

Future webinars to explore best practices and research needs will be held January 25th and March 15th.